Welcome to the e-CCO Library Archive!
P651
Postoperative complications after intestinal resection in Crohn’s disease: analysis from the Practicrohn study
E. Domènech*1, M. Barreiro-de Acosta2, A. Gutiérrez3, V. García4, M. D. Martín Arranz5, L. Cea-Calvo6, C. Romero6, B. Juliá6
1Hospital Universitari Germans Trias i Pujol and CIBERehd, Gastroenterology Unit, Badalona, Spain, 2Complejo Hospitalario Universitario de Santiago, Gastroenterology Unit, Santiago de Compostela, Spain, 3Hospital General Universitario Alicante, Gastroenterology unit, Alicante, Spain, 4Hospital Universitario Reina Sofia, Unidad Clinica de Aparato Digestivo, Cordoba, Spain, 5Hospital Universitario La Paz, Gastroenterology Unit, Madrid, Spain, 6MSD Spain, Medical Department, Madrid, Spain
P652
The prevalence of latent tuberculosis and hepatitis B found after systematic screening of patients starting with biological therapy in a low-endemic area
M. de Jong*1, 2, D. Roosen1, A. Peters3, A. Masclee1, 2, V. Verstraeten4, A. van Tubergen5, 6, M. Pierik1, 2
1Maastricht University Medical Centre+, Department of Internal Medicine, division of Gastroenterology and Hepatology, Maastricht, Netherlands, 2Maastricht University Medical Centre+, NUTRIM – School for Nutrition and Translational Research in Metabolism, Maastricht, Netherlands, 3Maastricht University Medical Centre+, Department of Internal Medicine, Maastricht, Netherlands, 4Maastricht University Medical Centre+, Department of Dermatology, Maastricht, Netherlands, 5Maastricht University Medical Centre+, Department of Internal Medicine, division of Rheumatology, Maastricht, Netherlands, 6Maastricht University Medical Centre+, CAPHRI - School for Public Health and Primary Care, Maastricht, Netherlands
P653
Prevalence and factors associated with fatigue in patients with inflammatory bowel disease: a multicentre study
C. Chavarría-Herbozo*1, M. J. Casanova1, M. Barreiro-de Acosta2, M. Chaparro1, E. Ezquiaga1, L. Bujanda3, M. Rivero4, F. Arguelles-Arias5, M.D. Martín-Arranz6, M. P. Martínez-Montiel7, M. Valls8, R. Ferreiro2, J. Llao9, I. Moraleja-Yudego10, F. Casellas11, B. Antolín-Melero12, X. Cortés13, R. Plaza14, J. R. Pineda15, M. Navarro-Llavat16, S. García-López17, P. Robledo-Andrés18, I. Marín-Jiménez19, E. Iglesias-Flores20, O. Merino21, F. Bermejo22, M. R. Arribas-López23, J.M. Banales3, B. Castro4, L. Castro-Laria5, R. Honrubia6, P. Almela8, J. P. Gisbert1
1Hospital Universitario de La Princesa, IIS-IP and CIBERehd, Gastroenterology Unit, Madrid, Spain, 2Hospital Clínico Universitario de Santiago, Gastroenterology Unit, Santiago de Compostela, Spain, 3Hospital de Donostia, Instituto Biodonostia, UPV/EHU and CIBEREHD, Gastroenterology Unit, Guipuzcoa, Spain, 4Hospital Universitario Marqués de Valdecilla, Gastroenterology Unit, Santander, Spain, 5Hospital Universitario Virgen de La Macarena, Gastroenterology Unit, Sevilla, Spain, 6Hospital Universitario La Paz, Gastroenterology Unit, Madrid, Spain, 7Hospital Universitario 12 de Octubre, Gastroenterology Unit, Madrid, Spain, 8Hospital General Universitario de Castellón, Gastroenterology Unit, Castellón, Spain, 9Hospital Sant Joan de Deu, Gastroenterology Unit, Manresa, Spain, 10Hospital Galdakao, Gastroenterology Unit, Vizcaya, Spain, 11Hospital Universitari Vall d’Hebron, Gastroenterology Unit, Barcelona, Spain, 12Hospital Clínico Universitario de Valladolid, Gastroenterology Unit, Valladolid, Spain, 13Hospital de Sagunto, Gastroenterology Unit, Valencia, Spain, 14Hospital Universitario Infanta Leonor, Gastroenterology Unit, Madrid, Spain, 15Hospital Álvaro Cunqueiro, Gastroenterology Unit, Vigo, Spain, 16Hospital de Sant Joan Despí Moisès Broggi, Gastroenterology Unit, Barcelona, Spain, 17Hospital Universitario Miguel Servet, Gastroenterology Unit, Zaragoza, Spain, 18Hospital Universitario San Pedro Alcántara, Gastroenterology Unit, Cáceres, Spain, 19Hospital Gregorio Marañón and IiSGM, Gastroenterology Unit, Madrid, Spain, 20Hospital Universitario Reina Sofía, Gastroenterology Unit, Córdoba, Spain, 21Hospital Universitario de Cruces, Gastroenterology Unit, Bilbao, Spain, 22Hospital Universitario de Fuenlabrada, Gastroenterology Unit, Madrid, Spain, 23Hospital Universitario Infanta Sofía, Gastroenterology Unit, Madrid, Spain
P654
Factors associated with non-adherence to medical therapy in inflammatory bowel disease
M. L. De Castro*1, N. Martínez2, A. Martín2, L. Sanromán1, M. Figueira1, V. Hernández1, J. R. Pineda1, J. Martínez-Cadilla1, S. Pereira1, V. Del Campo3, J.-I. Rodríguez-Prada1
1Hospital Alvaro Cunqueiro. Complexo Hospitalario Universitario de Vigo.CHUVI, Gastroenterology, Vigo, Spain, 2Hospital Alvaro Cunqueiro. Complexo Hospitalario Universitario de Vigo.CHUVI, Hospital Pharmacy, Vigo, Spain, 3Hospital Alvaro Cunqueiro. Complexo Hospitalario Universitario de Vigo.CHUVI, Epidemiology, Vigo, Spain
P655
Biosimilar infliximab CT-P13 treatment in patients with inflammatory bowel diseases: a 1-year, single-centre retrospective study
T. Hlavaty*, A. Krajcovicova, I. Sturdik, J. Letkovsky, T. Koller, J. Toth, M. Huorka
Comenius University, Faculty of Medicine and University Hospital Bratislava, Fifth Department of Internal Medicine, Bratislava, Slovakia
P656
Infliximab therapy for intestinal, neuro-, and vascular Behcet disease: efficacy, safety, and pharmacokinetics in a multicentre prospective study
T. Hibi*1, S. Hirohata2, H. Kikuchi3, U. Tateishi4, N. Sato5, K. Ozaki5, K. Kondou5, Y. Ishigatsubo6
1Kitasato University Kitasato Institute Hospital, Centre for Advanced IBD Research and Treatment, Tokyo, Japan, 2Kitasato University School of Medicine, Department of Rheumatology and Infectious Diseases, Sagamihara, Japan, 3Teikyo University School of Medicine, Department of Internal Medicine, Tokyo, Japan, 4Tokyo Medical and Dental University Graduate School of Medicine, Department of Diagnostic Radiology and Nuclear Medicine, Tokyo, Japan, 5Mitsubishi Tanabe Pharma Corporation, Osaka, Japan, 6Yokohama City University, Yokohama, Japan
P657
Health-related quality of life of patients with inflammatory bowel disease is increased during treatment with biological therapy
A. S. Holdam, P. Bager*, J. F. Dahlerup
Aarhus University Hospital, Department of Hepatology and Gastroenterology, Aarhus, Denmark
P658
Long-term outcome of endoscopic balloon dilation for ileocolonic Crohn’s strictures
T. Taida*, T. Nakagawa, S. Hamanaka, H. Koseki, T. Sakurai, K. Okimoto, K. Saito, D. Maruoka, T. Matsumura, M. Arai, T. Katsuno, O. Yokosuka
Chiba University, Department of Gastroenterology and Nephrology, Chiba, Japan
P659
A feasibility study with the telemedicine tool MyBiologicalCoach in The Netherlands
M. de Jong*1, 2, A. van Tubergen3, 4, A. Peters5, A. Masclee1, 2, V. Verstraeten6, M. Pierik1, 2
1Maastricht University Medical Centre+, Department of Internal Medicine, division of Gastroenterology and Hepatology, Maastricht, Netherlands, 2Maastricht University Medical Centre+, NUTRIM – School for Nutrition and Translational Research in Metabolism, Maastricht, Netherlands, 3Maastricht University Medical Centre+, Department of Internal Medicine, division of Rheumatology, Maastricht, Netherlands, 4Maastricht University Medical Centre+, CAPHRI - School for Public Health and Primary Care, Maastricht, Netherlands, 5Maastricht University Medical Centre+, Department of Internal Medicine, Maastricht, Netherlands, 6Maastricht University Medical Centre+, Department of Dermatology, Maastricht, Netherlands
P660
A Danish cross-sectional study: autoimmune and chronic inflammatory disorders associated with Crohn’s disease
M. Halling*1, J. Kjeldsen1, T. Knudsen2, J. Nielsen3, L. Koch Hansen4
1Odense University Hospital, Department of Gastroenterology, Odense, Denmark, 2Esbjerg Hospital, Dept. of Gastroenterology and Hepatology, Esbjerg, Denmark, 3Odense University Hospital, Department of Clinical Epidemiology, Odense, Denmark, 4Vejle Hospital, Dept. of Gastroenterology and Hepatology, Vejle, Denmark
P661
Abscess and fistula in Crohn’s disease
K. Sahnan*1, A. Askari1, S. Adegbola1, P. Tozer1, R. Phillips1, A. Hart2, O. Faiz1
1St Mark’s Hospital, Colorectal Surgery, London, United Kingdom, 2St Mark’s Hospital, IBD/Physiology, London, United Kingdom
P662
Evolution of IBD incidence, disease phenotype, and mortality; 20 years of epidemiologic research in the Dutch population-based inflammatory bowel disease South Limburg cohort
T. van den Heuvel*1, 2, S. Jeuring1, 2, M. Zeegers3, 4, D. van Dongen1, A. Wolters1, A. Masclee1, 2, M. Romberg-Camps5, L. Oostenbrug5, M. Pierik1, 2, D. Jonkers1, 2
1Maastricht University Medical Centre+, Division of Gastroenterology and Hepatology, Maastricht, Netherlands, 2Maastricht University Medical Centre+, Nutrim - School of Nutrition and Translational Research in Metabolism, Maastricht, Netherlands, 3Maastricht University Medical Centre+, Department of Complex Genetics, Maastricht, Netherlands, 4Maastricht University Medical Centre+, Caphri - School of Public Health and Primary Care, Maastricht, Netherlands, 5Zuyderland Medical Centre, Department of Internal Medicine, Sittard-Geleen-Heerlen, Netherlands
P663
Time trends in the epidemiology and outcome of perianal and rectovaginal fistulising Crohn’s disease: results from the population-based inflammatory bowel disease South Limburg cohort
S. Jeuring*1, 2, K. Göttgens3, R. Sturkenboom3, M. Romberg-Camps4, L. Oostenbrug5, J. Melenhorst3, L. Stassen3, A. Masclee1, 2, D. Jonkers1, 2, M. Pierik1, 2, S. Breukink3
1Maastricht University Medical Centre, Internal Medicine - Division of Gastroenterology and Hepatology, Maastricht, Netherlands, 2Maastricht University Medical Centre, NUTRIM - School for Nutrition and Translational Research in Metabolism, Maastricht, Netherlands, 3Maastricht University Medical Centre, General Surgery, Maastricht, Netherlands, 4Zuyderland Medical Centre, Internal Medicine and Gastroenterology-Hepatology, Sittard-Geleen, Netherlands, 5Zuyderland Medical Centre, Internal Medicine and Gastroenterology-Hepatology, Heerlen, Netherlands
P664
Natural history of Crohn’s disease in elderly patients diagnosed over the age of 70 years: a population-based study
m. fumery*1, B. Pariente2, h. sarter3, C. Charpentier4, L. Armengol-Debeir4, J.-L. Dupas5, H. Coevoet6, L. Peyrin-biroulet7, C. Gower-Rousseau8, G. Savoye4
1Amiens University Hospital, Department of Gastroenterology and Hepatology, Amiens, France, 2CHRU Lille, Department of Gastroenterology, Lille, France, 3CHRU Lille, Department of Biostatistics EA 2694, Lille, France, 4CHU Rouen, Department of Gastroenterology and Hepatology, Rouen, France, 5Amiens University Hospital, Hepatogastroenterology, Amiens, France, 6Hopital Privé, Les Bonnettes, Arras, France, 7CHU Nancy, Department of Gastroenterology and Hepatology, Vandoeuvre-Lès-Nancy, France, 8CHRU Lille, Department of Epidemiology, EPIMAD Registry, Lille, France
P665
Familial aggregation of inflammatory bowel disease on the Faroe Islands: a Faroese inflammatory bowel disease cohort study
K. R. Nielsen*1, 2, J. Olsen1, G. Andorsdóttir2, E. Gislason2, J. Burisch3
1The National Hospital of the Faroe Islands, Medical department, Tórshavn, Faroe Islands, 2Genetic Biobank, Tórshavn, Faroe Islands, 3North Zealand University Hospital, Department of Gastroenterology, Frederikssund, Denmark
P666
Fruit consumption may protect against the development of intestinal inflammation via modification of microbial composition
L. Godny*1, N. Maharshak1, L. Yahav1, N. Fliss-Isakov2, U. Gophna3, H. Tulchinsky4, I. Dotan1
1Tel Aviv Sourasky Medical Centre, IBD Centre, Department of Gastroenterology and Liver Diseases, affiliated to the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel, 2Tel Aviv Sourasky Medical Centre, Department of Gastroenterology and Liver Diseases, affiliated to the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel, 3Tel Aviv University, Department of Molecular Microbiology and Biotechnology, George S. Wise Faculty of Life Sciences, Tel Aviv, Israel, 4Tel Aviv Sourasky Medical Centre, Proctology Unit, Department of Surgery, affiliated to the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
P667
The clinical features of patients with newly diagnosed moderate-to-severe ulcerative colitis in Korea: a population-based inception cohort study (the MOSAIK cohort)
C. K. Lee*1, S. N. Hong2, J. P. Im3, B. D. Ye4, J. M. Cha1, S.-A. Jung5, K.-M. Lee6, D. I. Park2, Y. T. Jeen7, Y. S. Park8, H. J. Kim1, Y. J. Kim9, T. O. Kim10, G. S. Seo11, E. S. Kim12, J. S. Koo7, J. S. Kim3, B. I. Jang13, J. E. Shin14, J. W. Kim15, Y. S. Park16, J. H. Cheon17, Y. S. Kim18, H. S. Kim19, J. Lee20, J. J. Park17, G. A. Song21, C. S. Eun22, S. J. Shin23, K. C. Huh24, H.-S. Kim25, C. H. Choi26, H. S. Kim27, Y. Kim27
1Kyung Hee University School of Medicine, Internal Medicine, Seoul, South Korea, 2Sungkyunkwan University School of Medicine, Seoul, South Korea, 3Seoul National University College of Medicine and Liver Research Institute, Seoul, South Korea, 4University of Ulsan College of Medicine, Seoul, South Korea, 5Ewha Woman’s University School of Medicine, Seoul, South Korea, 6The Catholic University of Korea College of Medicine, Seoul, South Korea, 7Korea University College of Medicine, Seoul, South Korea, 8Eulji University College of Medicine, Eulji hospital, Seoul, South Korea, 9Gachon University Gil Medical Centre, Incheon, South Korea, 10Inje University College of Medicine, Busan, South Korea, 11Wonkwang University School of Medicine, Iksan, South Korea, 12Keimyung University School of Medicine, Daegu, South Korea, 13Yeungnam University College of Medicine, Daegu, South Korea, 14Dankook University College of Medicine, Cheonan, South Korea, 15Seoul National University Boramae Hospital, Seoul, South Korea, 16Seoul National University Bundang Hospital, Bundang, South Korea, 17Yonsei University College of Medicine, Seoul, South Korea, 18Inje University College of Medicine, Seoul, South Korea, 19Chonnam National University Medical School, Gwangju, South Korea, 20Chosun University College of Medicine, Gwangju, South Korea, 21Pusan National University School of Medicine and Biomedical Research Institute, Busan, South Korea, 22Hanyang University Guri Hospital, Guri, South Korea, 23Ajou University School of Medicine, Suwon, South Korea, 24Konyang University College of Medicine, Daejeon, South Korea, 25Yonsei University Wonju College of Medicine, Wonju, South Korea, 26Chung-Ang University College of Medicine, Seoul, South Korea, 27Janssen Korea, Medical affairs, Seoul, South Korea
P668
Medical therapy, surgery and hospitalisation rates during the 2- and 3-year follow-up of the 2011 ECCO-EpiCom cohort
Z. Vegh*1, J. Burisch2, I. Kaimakliotis3, D. Duricova4, K. Carlsen2, K. R. Nielsen5, D. K. Christodoulou6, L. Lakatos7, S. Odes8, R. D’Incà9, G. Kiudelis10, S. Turcan11, F. Magro12, 13, 14, A. Goldis15, V. Hernandez16, S. Bell17, E. Langholz18, P. Munkholm2, P. Lakatos1
1Semmelweis University, First Department of Medicine, Budapest, Hungary, 2North Zealand Hospital, University of Copenhagen, Gastro Unit, Medical Section, Copenhagen, Denmark, 3Nicosia private practice, Nicosia private practice, Nicosia, Cyprus, 4Charles University, IBD Centre ISCARE, Prague, Czech Republic, 5The National Hospital of the Faroe Islands, Medical Department, Torshavn, Faroe Islands, 6Faculty of Medicine, University of Ioannina, First Division of Internal Medicine and Division of Gastroenterology, Ioannina, Greece, 7Csolnoky F. Province Hospital, Department of Medicine, Veszprem, Hungary, 8Soroka Medical Centre and Ben-Gurion University of the Negev, Department of Gastroenterology and Hepatology, Beer Sheva, Israel, 9Università di Padova, U. O. Gastroenterologia, Azienda Ospedaliera, Padova, Italy, 10Lithuanian University of Health Sciences, Institute for Digestive Research, Kaunas, Lithuania, 11State University of Medicine and Pharmacy, Department of Gastroenterology, Chisinau, Moldova, Republic of, 12Hospital de São João, Department of Gastroenterology, Porto, Portugal, 13Oporto Medical School, Department of Pharmacology and Therapeutics, Porto, Portugal, 14University of Porto, 8 MedInUP - Centre for Drug Discovery and Innovative Medicines, Porto, Portugal, 15University of Medicine ‘Victor Babes’, Clinic of Gastroenterology, Timisoara, Romania, 16Complexo Hospitalario Universitario de Vigo, Gastroenterology Department, Vigo, Spain, 17St Vincent’s Hospital, Department of Gastroenterology, Melbourne, Victoria, Australia, 18Herlev and Gentofte Hospital, Department C, Gastroenterology Section, Hellerup, Denmark
P669
The prevalence of alexithymia in inflammatory bowel disease: a systematic review and meta-analysis
C. Hopkins*1, C. Moulton2
1Berkshire Healthcare NHS Foundation Trust, Prospect Park Hospital, Reading, United Kingdom, 2Institute of Psychiatry, Psychology & Neuroscience, King’s College London, London, United Kingdom
P670
Mortality and its predictors in inflammatory bowel disease: a hospital-based cohort study from Korea 1977–2013
H.-S. Lee*1, J. W. Choe1, H. J. Lee1, K. Chang2, G.-U. Kim2, S. W. Hwang2, S. H. Park2, D.-H. Yang2, K.-J. Kim2, B. D. Ye2, J.-S. Byeon2, S.-J. Myung2, S.-K. Yang2
1Asan Medical Centre, University of Ulsan College of Medicine, Health Screening and Promotion Centre, Seoul, South Korea, 2Asan Medical Centre, University of Ulsan College of Medicine, Department of Gastroenterology, Seoul, South Korea